Impact of Deceased-donor Acute Kidney Injury on Kidney Transplantation.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
22 Nov 2023
22 Nov 2023
Historique:
pubmed:
22
11
2023
medline:
22
11
2023
entrez:
22
11
2023
Statut:
aheadofprint
Résumé
Even as record numbers of deceased donors are undergoing organ recovery, the global transplant community continues to struggle with a shortage of donor organs and a high organ discard rate. Acute kidney injury (AKI) occurs in many hospitalized patients, including up to 25% of patients in critical condition. Registry studies have shown a significant increase in nonrecovery or organ discard rates in AKI donors, despite most studies reporting similar clinical outcomes compared with non-AKI donors. This review aims to capture the salient information learned from these studies and to summarize the efforts that have been made to gain a more granular understanding of how kidneys from donors with AKI behave posttransplant. In particular, we reviewed the studies that analyzed the clinical outcomes in different stages of AKI and AKI in marginal donors, such as kidney donor profile index of >85%, older donors, and donation after circulatory death donors. We summarized studies investigating molecular biomarkers, transcriptomics, and possible future therapeutic targets for postdonation AKI.
Identifiants
pubmed: 37990359
doi: 10.1097/TP.0000000000004848
pii: 00007890-990000000-00601
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Schladt DP, Israni AK. OPTN/SRTR 2021 Annual Data Report: Introduction. Am J Transplant. 2023;23(2 Suppl 1):S12–S20.
Eurotransplant. Statistics registry. Available at https://statistics.eurotransplant.org . Accessed July 24, 2023.
ANZDATA. 45th Annual Report 2022 (Data to 2021): Chapter 6. Australian Transplant Waiting List. Available at https://www.anzdata.org.au/wp-content/uploads/2022/09/Chapter-6-Australian-Transplant-Waiting-List-ANZDATA-Annual-Report-2022.pdf . Accessed July 24, 2023.
Kayler LK, Garzon P, Magliocca J, et al. Outcomes and utilization of kidneys from deceased donors with acute kidney injury. Am J Transplant. 2009;9:367–373.
Mohan S, Chiles MC, Patzer RE, et al. Factors leading to the discard of deceased donor kidneys in the United States. Kidney Int. 2018;94:187–198.
Sonnenberg EM, Hsu JY, Cohen JB, et al. Acute kidney injury in deceased organ donors and kidney transplant outcomes: a national cohort study using a novel data source. Ann Surg. 2022;276:e982–e990.
Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81:442–448.
Boffa C, van de Leemkolk F, Curnow E, et al. Transplantation of kidneys from donors with acute kidney injury: friend or foe? Am J Transplant. 2017;17:411–419.
Ha J, Jung CW, Choi S, et al.; Korean Organ Transplantation Registry Study group. Impact of acute kidney injury on graft outcomes of deceased donor kidney transplantation: a nationwide registry-based matched cohort study in Korea. PLoS One. 2021;16:e0260076.
Hall IE, Akalin E, Bromberg JS, et al. Deceased-donor acute kidney injury is not associated with kidney allograft failure. Kidney Int. 2019;95:199–209.
Hall IE, Schroppel B, Doshi MD, et al. Associations of deceased donor kidney injury with kidney discard and function after transplantation. Am J Transplant. 2015;15:1623–1631.
Scurt FG, Ernst A, Wassermann T, et al. Short-term outcomes after transplantation of deceased donor kidneys with acute kidney injury: a retrospective analysis of a multicenter cohort of marginal donor kidneys with post-explantation biopsies. Int Urol Nephrol. 2023;55:115–127.
Pei J, Cho Y, See YP, et al. Impact of deceased donor with acute kidney injury on subsequent kidney transplant outcomes: an ANZDATA registry analysis. PLoS One. 2021;16:e0249000.
Jung CW, Jorgensen D, Sood P, et al. Outcomes and factors leading to graft failure in kidney transplants from deceased donors with acute kidney injury: a retrospective cohort study. PLoS One. 2021;16:e0254115.
Liu C, Hall IE, Mansour S, et al. Association of deceased donor acute kidney injury with recipient graft survival. JAMA Netw Open. 2020;3:e1918634.
Mansour SG, Khoury N, Kodali R, et al. Clinically adjudicated deceased donor acute kidney injury and graft outcomes. PLoS One. 2022;17:e0264329.
Lee MH, Jeong EG, Chang JY, et al. Clinical outcome of kidney transplantation from deceased donors with acute kidney injury by Acute Kidney Injury Network criteria. J Crit Care. 2014;29:432–437.
Garner M, Jay CL, Sharda B, et al. Long-term outcomes of kidney transplantation from deceased donors with terminal acute kidney injury: single center experience and literature review. Clin Transplant. 2023;37:e14886.
Echterdiek F, Kitterer D, Dippon J, et al. Outcome of kidney transplantations from ≥65-year-old deceased donors with acute kidney injury. Clin Transplant. 2022;36:e14612.
Jadlowiec CC, Hanna WA, Ninan J, et al. Transplant outcomes using kidneys from high KDPI acute kidney injury donors. Clin Transplant. 2021;35:e14279.
Jadlowiec CC, Heilman RL, Smith ML, et al. Transplanting kidneys from donation after cardiac death donors with acute kidney injury. Am J Transplant. 2020;20:864–869.
van der Windt DJ, Mehta R, Jorgensen DR, et al. Donor acute kidney injury and its effect on 1-year post-transplant kidney allograft fibrosis. Clin Transplant. 2020;34:e13770.
Torabi J, Graham JA, Choinski K, et al. Young donors with severe acute kidney injury offer an opportunity to expand the donor pool. Am J Surg. 2019;218:7–13.
Heilman RL, Smith ML, Kurian SM, et al. Transplanting kidneys from deceased donors with severe acute kidney injury. Am J Transplant. 2015;15:2143–2151.
Li MT, Ramakrishnan A, Yu M, et al. Effects of delayed graft function on transplant outcomes: a meta-analysis. Transplant Direct. 2023;9:e1433.
Heilman RL, Smith ML, Smith BH, et al. Progression of interstitial fibrosis during the first year after deceased donor kidney transplantation among patients with and without delayed graft function. Clin J Am Soc Nephrol. 2016;11:2225–2232.
Lia D, Singer P, Nair V, et al. DCD renal transplantation from donors with acute kidney injury. Transplantation. 2021;105:886–890.
Boros P, Bromberg JS. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant. 2006;6:652–658.
Nieuwenhuijs-Moeke GJ, Pischke SE, Berger SP, et al. Ischemia and reperfusion injury in kidney transplantation: relevant mechanisms in injury and repair. J Clin Med. 2020;9:253.
Palmisano A, Gandolfini I, Delsante M, et al. Acute kidney injury (AKI) before and after kidney transplantation: causes, medical approach, and implications for the long-term outcomes. J Clin Med. 2021;10:1484.
Giral-Classe M, Hourmant M, Cantarovich D, et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int. 1998;54:972–978.
de Sandes-Freitas TV, Felipe CR, Aguiar WF, et al. Prolonged delayed graft function is associated with inferior patient and kidney allograft survivals. PLoS One. 2015;10:e0144188.
Lim WH, Johnson DW, Teixeira-Pinto A, et al. Association between duration of delayed graft function, acute rejection, and allograft outcome after deceased donor kidney transplantation. Transplantation. 2019;103:412–419.
Nita GE, Gopal JP, Khambalia HA, et al. Kidney transplantation from donors with acute kidney injury: are the concerns justified? A systematic review and meta-analysis. Transpl Int. 2023;36:11232.
Budhiraja P, Reddy KS, Butterfield RJ, et al. Duration of delayed graft function and its impact on graft outcomes in deceased donor kidney transplantation. BMC Nephrol. 2022;23:154.
Hall IE, Reese PP, Mansour SG, et al. Deceased-donor acute kidney injury and BK polyomavirus in kidney transplant recipients. Clin J Am Soc Nephrol. 2021;16:765–775.
Parikh CR, Hall IE, Bhangoo RS, et al. Associations of perfusate biomarkers and pump parameters with delayed graft function and deceased donor kidney allograft function. Am J Transplant. 2016;16:1526–1539.
Reese PP, Hall IE, Weng FL, et al. Associations between deceased-donor urine injury biomarkers and kidney transplant outcomes. J Am Soc Nephrol. 2016;27:1534–1543.
Koyawala N, Reese PP, Hall IE, et al. Urine injury biomarkers are not associated with kidney transplant failure. Transplantation. 2020;104:1272–1279.
Reese PP, Doshi MD, Hall IE, et al. Deceased-donor acute kidney injury and acute rejection in kidney transplant recipients: a multicenter cohort. Am J Kidney Dis. 2023;81:222–231.e1.
Mansour SG, Liu C, Jia Y, et al. Uromodulin to osteopontin ratio in deceased donor urine is associated with kidney graft outcomes. Transplantation. 2021;105:876–885.
Famulski KS, de Freitas DG, Kreepala C, et al. Molecular phenotypes of acute kidney injury in kidney transplants. J Am Soc Nephrol. 2012;23:948–958.
Mengel M, Chang J, Kayser D, et al. The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant. 2011;11:708–718.
Halloran PF, Bohmig GA, Bromberg J, et al.; INTERCOMEX Investigators. Archetypal analysis of injury in kidney transplant biopsies identifies two classes of early aKI. Front Med (Lausanne). 2022;9:817324.
Mas VR, Archer KJ, Yanek K, et al. Gene expression patterns in deceased donor kidneys developing delayed graft function after kidney transplantation. Transplantation. 2008;85:626–635.
Cippà PE, Sun B, Liu J, et al. Transcriptional trajectories of human kidney injury progression. JCI Insight. 2018;3:e123151.
von Moos S, Akalin E, Mas V, et al. Assessment of organ quality in kidney transplantation by molecular analysis and why it may not have been achieved, yet. Front Immunol. 2020;11:833.
Archer KJ, Bardhi E, Maluf DG, et al. Pretransplant kidney transcriptome captures intrinsic donor organ quality and predicts 24-month outcomes. Am J Transplant. 2022;22:2515–2528.
Ledeganck KJ, Gielis EM, Abramowicz D, et al. MicroRNAs in AKI and kidney transplantation. Clin J Am Soc Nephrol. 2019;14:454–468.
Guo D, Fan Y, Yue JR, et al. A regulatory miRNA-mRNA network is associated with transplantation response in acute kidney injury. Hum Genomics. 2021;15:69.
McDaniels JM, Shetty AC, Kuscu C, et al. Single nuclei transcriptomics delineates complex immune and kidney cell interactions contributing to kidney allograft fibrosis. Kidney Int. 2023;103:1077–1092.
Menon R, Bomback AS, Lake BB, et al.; Kidney Precision Medicine Project. Integrated single-cell sequencing and histopathological analyses reveal diverse injury and repair responses in a participant with acute kidney injury: a clinical-molecular-pathologic correlation. Kidney Int. 2022;101:1116–1125.
Malinoski D, Saunders C, Swain S, et al. Hypothermia or machine perfusion in kidney donors. N Engl J Med. 2023;388:418–426.
De Beule J, Vandendriessche K, Pengel LHM, et al. A systematic review and meta-analyses of regional perfusion in donation after circulatory death solid organ transplantation. Transpl Int. 2021;34:2046–2060.
Miñambres E, Suberviola B, Dominguez-Gil B, et al. Improving the outcomes of organs obtained from controlled donation after circulatory death donors using abdominal normothermic regional perfusion. Am J Transplant. 2017;17:2165–2172.
Shapey IM, Muiesan P. Regional perfusion by extracorporeal membrane oxygenation of abdominal organs from donors after circulatory death: a systematic review. Liver Transpl. 2013;19:1292–1303.
Anwar IJ, DeLaura I, Ladowski J, et al. Complement-targeted therapies in kidney transplantation-insights from preclinical studies. Front Immunol. 2022;13:984090.
Schroppel B, Heeger PS, Thiessen-Philbrook H, et al. Donor urinary C5a levels independently correlate with posttransplant delayed graft function. Transplantation. 2019;103:e29–e35.
Schroppel B, Akalin E, Baweja M, et al. Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: results of two randomized controlled pilot trials. Am J Transplant. 2020;20:564–572.
Jordan SC, Choi J, Aubert O, et al. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients. Am J Transplant. 2018;18:2955–2964.